Davis Polk

William A. Curran

Deals
10
Latest
Jun 2026
Most deals in
Medtech

Firm

Deals by year
William A. Curran: deals by year051020252026 YTD: 10 M&A102026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals William A. Curran was named on, most recent first
Jun 2026 TARGAN –Merck Animal HealthAcquisitionLegal adviser to TARGAN (target)Announced–Agtech+2Merck Animal Health acquisition of TARGAN
May 2026 FMC India Private FMCCrystal Crop ProtectionAcquisitionLegal adviser to FMC (target)Announced252.0Chemicals+1Crystal Crop Protection acquisition of FMC India Private
May 2026 two North American beverage closures compression molding facilities AmcorClosure Systems International GroupAsset saleLegal adviser to Cerberus Capital Management and Closure Systems International Group (acquirer)Announced–Packaging+1Closure Systems International Group acquisition of two North American beverage closures compression molding facilities
May 2026 S+S Industries –Cerberus Capital Management, L.P.AcquisitionLegal adviser to Cerberus Capital Management, L.P. (acquirer)Announced–Data Centers+1Cerberus Capital Management, L.P. acquisition of S+S Industries
Mar 2026 Agency lending business of Basis Multifamily Finance I Basis Multifamily Finance IZions Bancorporation, N.A.Asset saleLegal adviser to Basis Investment Group, LLC and its subsidiary Basis Multifamily Finance I (target)Completed–Real Estate+1Zions Bancorporation, N.A. acquisition of Agency lending business of Basis Multifamily Finance I
Mar 2026 BVNK –MastercardAcquisitionLegal adviser to Mastercard (acquirer)Completed1,800.0Payments Infrastructure+1Mastercard acquisition of BVNK
Feb 2026 Uromedica –Coloplast A/SAcquisitionLegal adviser to Coloplast A/S (acquirer)Announced–MedtechColoplast A/S acquisition of Uromedica
Jan 2026 AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 AbelZetaAstraZenecaAsset saleLegal adviser to AbelZeta (target)Announced630.0Biotech+2AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031
Jan 2026 Mentee Robotics –Mobileye GlobalAcquisitionLegal adviser to Mobileye Global (acquirer)Announced900.0AI+1Mobileye Global acquisition of Mentee Robotics
Jan 2026 Conformal Medical –W. L. Gore & AssociatesAcquisitionLegal adviser to W. L. Gore & Associates (acquirer)Announced–Medtech+1W. L. Gore & Associates acquisition of Conformal Medical

Deals where William A. Curran is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.